Improvement of eosinophilic chronic rhinosinusitis after infection with severe acute respiratory syndrome corona virus 2 during dupilumab therapy: A case report.

Koike-Ieki, Mariko; Kagoya, Ryoji; Toma-Hirano, Makiko; Sasajima, Yuko; Ito, Ken

Koike-Ieki, Mariko; Kagoya, Ryoji; Toma-Hirano, Makiko; Sasajima, Yuko; Ito, Ken.

Afiliación

Koike-Ieki M; Department of Otolaryngology, Faculty of Medicine, Teikyo University, Tokyo, Japan.
Kagoya R; Department of Otolaryngology, Faculty of Medicine, Teikyo University, Tokyo, Japan.
Toma-Hirano M; Department of Otorhinolaryngology-Head and Neck Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Sasajima Y; Department of Otolaryngology, Faculty of Medicine, Teikyo University, Tokyo, Japan.
Ito K; Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan.

Front Allergy ; 4: 1053777, 2023.

Article en En | MEDLINE | ID: mdl-36819831

Palabras clave

cytokine balance; dupilumab; dysosmia; eosinophilic chronic rhinosinusitis; severe acute respiratory syndrome corona virus 2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Allergy Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google